18.10.2014 Views

Rudolf Magnus Bulletin 21 March 2006 - UMC Utrecht

Rudolf Magnus Bulletin 21 March 2006 - UMC Utrecht

Rudolf Magnus Bulletin 21 March 2006 - UMC Utrecht

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Rudolf</strong> <strong>Magnus</strong> <strong>Bulletin</strong> <strong>21</strong><br />

<strong>March</strong> <strong>2006</strong><br />

interview<br />

PINE assessed pain in herpes zoster<br />

Chronic pain syndrome is a common complication of<br />

herpes zoster. Bart Van Wijck, Wim Opstelten and<br />

colleagues performed the first ever randomised, controlled<br />

trial to establish the effect of a single injection<br />

in the spine with both anti-inflammatory and painkilling<br />

drugs. They demonstrated, in a Lancet article,<br />

that these injections, although common practice, had<br />

only limited effect and were ineffective for long-term<br />

treatment of chronic pain after herpes zoster.<br />

Postherpetic neuralgia is a neuropathic pain syndrome<br />

associated with the reactivation of varicella zoster virus<br />

(herpes zoster), which resides in latent form in sensory<br />

trigeminal and dorsal root ganglia in the spine after primary<br />

infection as varicella (chickenpox). This pain syndrome is<br />

the most frequent complication of herpes zoster, which<br />

occurs in 9–34% of varicella infections. Postherpetic<br />

neuralgia often negatively affects quality of life, because<br />

many patients develop severe physical, occupational, and<br />

social disabilities as a consequence of their chronic pain.<br />

Once the syndrome has developed, the effect of treatment<br />

is disappointing. Although the effectiveness of a varicella<br />

zoster vaccine on prevention of zoster-related morbidity is<br />

promising, postherpetic neuralgia will remain a serious<br />

problem for many years. Antiviral therapy can shorten the<br />

duration of zoster-associated pain, but many patients with<br />

herpes zoster develop postherpetic neuralgia despite such<br />

treatment. Van Wijck: “As herpes zoster goes together with<br />

local inflammation of the dorsal root ganglion, and this<br />

inflammation is considered to be an important causative<br />

factor for postherpetic neuralgia, interventions can be<br />

aimed at reducing this inflammation. Although epidural<br />

injections have been used for decades both to treat zosterassociated<br />

pain and to prevent postherpetic neuralgia, the<br />

effectiveness of this treatment was not previously assessed<br />

in a randomised clinical trial.”<br />

The PINE study (Prevention by epidural Injection of<br />

postherpetic Neuralgia in the Elderly), an open randomised<br />

multicentre trial, was designed to quantify the effectiveness<br />

of a single epidural injection of 80 mg methylprednisolone<br />

and 10 mg bupivacaine in addition to<br />

standard treatment during the acute phase of herpes<br />

zoster in preventing postherpetic neuralgia. A total of 598<br />

patients was included older than 50 years with acute<br />

herpes zoster (rash


PhD theses<br />

<strong>2006</strong>-4<br />

<strong>March</strong> 8, <strong>2006</strong><br />

Frank R. Van Genderen<br />

Functional limitations in severe haemophilia<br />

P.J.M. Helders, H.M. Van den Berg,<br />

N.L.U. Van Meeteren<br />

supervisors<br />

<strong>2006</strong>-5<br />

Predicting complications in SAH<br />

<strong>March</strong> 9, <strong>2006</strong><br />

Wouter J. Schuiling<br />

Extracerebral organ dysfunction and sleep disorders<br />

in subarachnoid haemorrhage<br />

G.J.E. Rinkel, A. Algra, A.W. De Weerd,<br />

P.J.W. Dennesen<br />

supervisors<br />

Cardiac and pulmonary complications are common in<br />

subarachnoid haemorrhage (SAH), but also other<br />

extracerebral complications are frequently observed.<br />

Wouter Schuiling found that these complications can<br />

be predicted and probably treated better if attention is<br />

given to cardiac troponin I. Incorporating signs of<br />

extracerebral organ dysfunction in grading scales can<br />

help in prognosticating outcome. Attention for sleep<br />

disorders can further improve long-term outcome.<br />

Schuiling performed an epidemiological study on a cohort<br />

of 172 patients with aneurysmal SAH, who were treated<br />

according to standard intensive care guidelines for at least<br />

2 weeks. Schuiling about the results; “ECG abnormalities<br />

have only limited value in predicting poor outcome. Cardiac<br />

troponin I appeared to be a powerful predictor for the<br />

occurrence of pulmonary and cardiac complications.<br />

Pulmonary oedema and depressed cardiac contractile<br />

function were frequently observed in the first 5 days after<br />

SAH. A depressed cardiac contractile function in at least<br />

one day in the first 5 days after SAH onset was more<br />

prevalent in patients with an elevated cardiac troponin I.<br />

Single transpulmonary thermodilution technique appeared<br />

to be a promising tool for monitoring SAH patients<br />

especially with elevated cardiac troponin I on admission.<br />

The simplified acute physiology score (SAPS II) is a useful<br />

and reliable prognosticator in SAH patients. This score<br />

may in some circumstances provide more information than<br />

specific SAH rating scales in predicting poor outcome or<br />

the occurrence of delayed cerebral ischemia. In patients<br />

with a good outcome according to the Rankin scale 50%<br />

complained of tiredness. In these patients disorders of<br />

sleep and wake occurred in one-third. Patients with severe<br />

sleep disturbances often have a considerably reduced<br />

quality of life.<br />

Schuiling summarizes: “Extracerebral organ dysfunction is<br />

frequently seen after SAH. Grading scales incorporating<br />

signs of extracerebral organ dysfunction should be used<br />

more frequently by neurologists and neurosurgeons<br />

treating SAH patients. Cardiac troponin I can be used as<br />

marker to identify patients who are at risk of developing<br />

cardiopulmonary complications and could benefit from<br />

early invasive hemodynamic monitoring. Additional studies<br />

using single transpulmonary thermodilution are required to<br />

study the effects of cardiac and pulmonary estimates on<br />

delayed cerebral ischemia and outcome in SAH patients.<br />

Also studies with extended follow-up are required to<br />

evaluate whether a therapeutic strategy taking into account<br />

cardiac index, cardiac contractile function and<br />

extravascular lung water can improve supportive therapy<br />

and outcome. The improvement of long-term outcome<br />

should focus on attention for sleep disorders in patients<br />

complaining of daytime fatigue, restless or non-restorative<br />

sleep, snoring, and restless legs syndrome.”<br />

Wouter Schuiling (April 4, 1968, Amsterdam). Secondary<br />

education (Rijksscholengemeenschap, Amersfoort), 1986;<br />

Medicine (Groningen University), MD 1995; registered as<br />

neurologist, 2004 (Medisch Centrum Haaglanden, Den Haag).<br />

During his residency in Neurology he started the research as<br />

described in this thesis. He presently works as neurologist in the<br />

Medisch Centrum Leeuwarden.<br />

<strong>2006</strong>-6<br />

Walking after stroke<br />

<strong>March</strong> 14, <strong>2006</strong><br />

Boudewijn J. Kollen<br />

Recovery of gait after stroke<br />

E. Lindeman, G. Kwakkel<br />

supervisors<br />

Boudewijn Kollen addressed the long-term recovery of<br />

hemiplegic gait in severely affected stroke patients, by<br />

clinimetric and prognostic, and by therapeutic intervenetion<br />

studies. He was able to identify the determinants<br />

of late outcome and he demonstrated that the<br />

long-term effects of intensity of stroke rehabilitation,<br />

implemented during the initial 20 post-stroke weeks,<br />

are maintained for up to one year.<br />

With the institutionalisation of stroke services across health<br />

care facilities a reduction in mortality rates, length of<br />

inpatient stay and improved independence in activities of<br />

daily living have been reported. Recently developed<br />

treatment strategies, that incorporate compensation<br />

strategies with a strong emphasis on functional training,<br />

may hold the key to optimal stroke rehabilitation. Kollen<br />

describes the long-term recovery of hemiplegic gait in<br />

web http://www.rudolfmagnus.nl coordination j.dekker@med.uu.nl, phone +31 30 253 8110


severely affected stroke patients. Based on the application<br />

of a repeated measurement research design, data were<br />

obtained within the first post-stroke year period. This<br />

information subsequently enabled the identification of timerelated<br />

changes and was used by Kollen to address the<br />

following main questions: Are intensive stroke rehabilitation<br />

programmes, implemented within the early and<br />

subacute post-stroke phases, worthwhile in terms of longterm<br />

functional gains and can this long-term recovery be<br />

estimated early after stroke onset for better individualised<br />

reliable therapeutic goal setting and discharge planning?<br />

For this purpose, Kollen studied early and late recovery<br />

patterns as functional recovery after stroke tends to be<br />

non-linear and time-dependent. Subsequently, this<br />

information was used in the interpretation of some of the<br />

mechanisms involved in the long-term recovery of<br />

hemiplegic gait and the impact of intensity of therapeutic<br />

interventions on this recovery. The main findings of<br />

Kollen’s clinimetric and prognostic studies indicate<br />

predictive relationships between early determinants and<br />

late outcome and the relevance of measuring frequently<br />

and longitudinally in order to take into consideration the<br />

non-linear time-dependent relationship of covariates with<br />

recovery of gait after stroke. In the subsequent therapeutic<br />

intervention studies Kollen demonstrated that the long-term<br />

effects of intensity of stroke rehabilitation, implemented<br />

during the initial 20 post-stroke weeks, are maintained for<br />

up to one year.<br />

Boudewijn Kollen (February 26, 1956). Physiotherapy<br />

(Amsterdam), 1976; Epidemiology (Vrije Universiteit,<br />

Amsterdam), 2004. Physiotherapist at the Valerius Clinic,<br />

Amsterdam (1976-83), St. Michael’s Hospital, Toronto, Canada<br />

(1983-86), Baycrest Centre for Geriatric Care, Toronto, Canada<br />

(1986-89), and the Isala Clinics, Zwolle. Presently he works at<br />

the Research Bureau, Isala Clinics, Zwolle.<br />

<strong>2006</strong>-7<br />

Do piglets suffer when the sow is stressed?<br />

<strong>March</strong> 30, <strong>2006</strong><br />

Godelieve Kranendonk<br />

Prenatal stress in pigs<br />

M.A.M. Taverne, V.M. Wiegant, E.D. Ekkel,<br />

E.J.H. Mulder<br />

supervisors<br />

Stress in pregnant sows can affect both the wellbeing<br />

and health of the sows and her piglets. Godelieve<br />

Kranendonk applied hormonal and social stress to<br />

pregnant sows and studied the behaviour and stress<br />

physiology of the piglets. Stress during gestation<br />

appeared to affect both performance and behaviour of<br />

the piglets.<br />

Prenatal stress may be a relevant issue for husbandry<br />

pigs, since pregnant sows likely experience stressful<br />

situations during gestation, for instance as a consequence<br />

of housing and management practice. This may result in<br />

prenatal stress for their piglets. Kranendonk studied<br />

whether body weight, behaviour, or HPA-axis activity of<br />

piglets were affected when their mothers are exposed to<br />

stressors during gestation. In a first series of experiments<br />

Kranendonk exposed pregnant sows to the stress<br />

hormone cortisol and studied the performance of their<br />

piglets. She demonstrated that piglets can indeed be<br />

affected by elevated maternal cortisol concentrations<br />

Courtesy of Godelieve Kranendonk<br />

during gestation in their body weight, growth, survival,<br />

behaviour, and adrenocortical response to ACTH. Further,<br />

female piglets have an enhanced fever response when<br />

challenged by lipopolysaccharide. Some of these effects<br />

(e.g., response to challenges and behaviour) depended on<br />

the period of gestation during which maternal cortisol<br />

concentrations were elevated, or on the sex of the<br />

offspring (e.g., with respect to behaviour).<br />

In another series of experiments Kranendonk applied mild<br />

stress to pregnant sows in the form of social challenge.<br />

Social challenges did not elicit elevated cortisol concentrations<br />

in the pregnant sows. Regular mixing of pregnant<br />

sows, which produced a mild form of social stress during<br />

the last month of gestation, did not affect piglet characteristics,<br />

which can possibly be explained by this lack of<br />

elevated maternal cortisol concentrations during gestation.<br />

The social rank of sows (measured as winning of more<br />

agonistic interactions than they lose) during gestation, did<br />

affect piglet performance (in particular body weight at<br />

weaning and lean meat percentage at slaughter) and<br />

behaviour in a new environment. Furthermore, effects of<br />

maternal treatment on piglet characteristics were studied<br />

until eight weeks of age (behaviour and adrenocortical<br />

aspects) or until slaughter. Kranendonk: “It would be<br />

relevant to study whether piglets face long-term<br />

consequences of maternal treatments as applied in the<br />

experiments. This would be especially important for gilts<br />

that are kept for breeding.”<br />

Kranendonk explains the broader perspective of her<br />

results: “Our studies provide data that indicate that<br />

elevated maternal cortisol concentrations and social rank<br />

of pregnant sows affect performance and behaviour of<br />

their offspring. Whether these piglets are better off or<br />

perform less optimal in daily stressful situations remains to<br />

be elucidated. Nevertheless, stress during gestation does<br />

impair welfare of the pregnant sow herself. Hence, pig<br />

farmers should minimise stress exposure for pregnant<br />

sows. The number of agonistic interactions of pregnant<br />

sows around the feeding station in group housing should<br />

be reduced, e.g., by use of a protected feeding area or<br />

distraction materials.”<br />

Godelieve Kranendonk (January 31, 1977, Rotterdam)<br />

Secondary education (Christelijke Scholengemeenschap<br />

Walcheren, Middelburg), 1995; Biology (Catholic University<br />

Nijmegen and <strong>Utrecht</strong> University), 2001. From 2001-2005 she<br />

worked on the project as described in her thesis. Presently she<br />

works at the Department of Farm Animal Health, Veterinary<br />

Faculty, University <strong>Utrecht</strong>.<br />

secretariat Universiteitsweg 100, 3584 CG <strong>Utrecht</strong>, The Netherlands, m.vandenadort@med.uu.nl, phone +31 30 253 8847


news<br />

Collaboration Institute of Psychiatry is funded<br />

The <strong>UMC</strong> <strong>Utrecht</strong> stimulates the internationalisation of the<br />

research within its perimeter. The major research institutes<br />

of the <strong>UMC</strong> <strong>Utrecht</strong> were invited to apply for a competitive<br />

grant of € 200,000. The Institute of Psychiatry, London,<br />

U.K., was identified as partner of our Institute for a<br />

strategic alliance. The Institute of Psychiatry is a large<br />

neuroscience institute of undisputed reputation, which is<br />

active on overlapping, and complementary, fields of<br />

neuroscience research. In the past years meetings were<br />

held at the Institute’s highest level to explore the possibilities<br />

for such an alliance. It was agreed that both the<br />

<strong>Rudolf</strong> <strong>Magnus</strong> Institute and the Institute of Psychiatry will<br />

facilitate close contacts between their staff members in<br />

order to actively encourage collaboration between both<br />

institutes. On January 24, <strong>2006</strong>, the <strong>UMC</strong> <strong>Utrecht</strong><br />

committee deciding on this issue announced that our<br />

Institute was awarded with this grant to stimulate contact<br />

and collaboration with the Institute of Psychiatry. With<br />

some additional financial support of both institutes, the<br />

programme (<strong>2006</strong>-2009) will support the collaboration by<br />

travel grants for staff, organising workshops, and by<br />

initiating a visiting professor programme. A list of planned<br />

workshops and formal information how to apply for support<br />

will be released soon.<br />

Olaf Cremer wins Pfizer NVIC Award<br />

Olaf Cremer, anaesthesiologist, has won the yearly award<br />

of the Netherlands Society for Intensive Care (NVIC); this<br />

year sponsored by Pfizer. The award is presented for the<br />

best PhD thesis in the Netherlands in the field of intensive<br />

care-related research. Cremer won the award with his<br />

thesis entitled, ‘Goal-directed intensive care of traumatic<br />

brain injury: pathophysiological and clinical studies’<br />

(October 5, 2005, See <strong>Rudolf</strong> <strong>Magnus</strong> <strong>Bulletin</strong> 16). The<br />

award consists of a sum of money, which is to be used in<br />

part to re-print (150 copies) Cremer’s thesis for distribution<br />

among all intensive care units in the Netherlands.<br />

Saskia Van der Hel Lecturer of the Year<br />

Saskia Van der Hel, assistant professor at the Department<br />

of Pharmacology and Anatomy, was award with the title<br />

‘Lecturer of the Year’ by the students of the <strong>UMC</strong> <strong>Utrecht</strong>.<br />

Van der Hel received this much envied title for her<br />

enthusiasm and her great ability to motivate students.<br />

Marike Broekman wins Talma Eykman Award<br />

The Talma Eyman Award is presented to excellent<br />

undergraduate students at the <strong>UMC</strong> <strong>Utrecht</strong> who have<br />

distinguished themselves during their research internship.<br />

On February 9, <strong>2006</strong>, this year’s award for medical<br />

students was presented to Marike Broekman (supervisor<br />

Peter Burbach, Dept Pharmacology and Anatomy) for her<br />

work entitled, “Adeno-associated virus vectors serotyped<br />

with AAV8 capsid are more efficient than AAV-1 or -2<br />

serotypes for widespread gene delivery to the neonatal<br />

mouse brain”. The work was performed at the Departments<br />

of Neurology and Neuroscience, Mass. General<br />

Hospital and Harvard Medical School, Charlestown, MA,<br />

USA.<br />

agenda<br />

<strong>March</strong> 1, <strong>Rudolf</strong> <strong>Magnus</strong> Seminar<br />

Ruud F.G.Toonen (CNCR, Vrije Universiteit, Amsterdam)<br />

‘Molecular Mechanisms of secretory vesicle targeting<br />

and docking’<br />

Stratenum Building, <strong>UMC</strong> <strong>Utrecht</strong>, Room 4.208, 16:00-17:00<br />

Contact j.pasterkamp@med.uu.nl<br />

<strong>March</strong> 3, Helmholtz Lecture<br />

David F. Clayton (University of Illinois, USA)<br />

‘Neurogenomics of bird song memory’<br />

‘Rode zaal’, Ruppert Building, Leuvenlaan 19, <strong>Utrecht</strong>, 16:00-17:00<br />

Contact, v.maassen@fss.uu.nll<br />

<strong>March</strong> 3, <strong>Rudolf</strong> <strong>Magnus</strong> Seminar<br />

Rustam Al-Shahi (University of Edinburgh, UK)<br />

‘'Epidemiology, prognosis and treatment of brain<br />

arteriovenous malformations’<br />

Lecture room, C3West, <strong>UMC</strong> <strong>Utrecht</strong>, 12:45-13:30<br />

Contact, J.vanBeijnum@umcutrecht.nl<br />

<strong>March</strong> 9, Winter Conference, Dutch Society of<br />

Psychophysiology<br />

‘Boothzaal’, University Library, Heidelberglaan 3, <strong>Utrecht</strong>, 10:00-<br />

17:00. Programme, www.rudolfmagnus.nl<br />

Contact, k.b.e.bocker@pharm.uu.nl<br />

<strong>March</strong> 17, Inaugural address Carl Moons<br />

Professor of Clinical Epidemiology.<br />

Academy Building, Domplein 29, <strong>Utrecht</strong>, 16:15<br />

<strong>March</strong> 31, Symp. on Pharmacotherapy for ADHD<br />

See for programme our website, http://www.rudolfmagnus.nl<br />

Contact, j.l.kenemans@fss.uu.nl<br />

April 19-27, Course on Neuropsychopharmacology<br />

Venue, partly in Amsterdam, Weesp, and <strong>Utrecht</strong>. Programme,<br />

http://www.rudolfmagnus.nl. Registration, eam.borghols@vumc.nl<br />

May 4-5, Meeting of the Association of European<br />

Psychiatrists - Neuroimaging Section<br />

‘Neuroimaging Change over Time in Psychiatry’<br />

Academy Building, Domplein 29, <strong>Utrecht</strong><br />

Programme and registration, http://www.rudolfmagnus.nl<br />

August 28-29, <strong>Rudolf</strong> <strong>Magnus</strong>-Helmholtz<br />

Summerschool<br />

Conference Centre Ottone, Kromme Nieuwegracht 62, <strong>Utrecht</strong>.<br />

Programme to be announced, check our website for updates,<br />

http://www.rudolfmagnus.nl<br />

September 8-9, Brain Days<br />

A two-days meeting with international experts on the<br />

theme, ‘Brain plasticity in children’.<br />

<strong>UMC</strong> <strong>Utrecht</strong>. Programme to be announced, check our website for<br />

updates, http://www.rudolfmagnus.nl<br />

November 8, <strong>Rudolf</strong> <strong>Magnus</strong> Symposium<br />

Including the <strong>Rudolf</strong> <strong>Magnus</strong> Lecture <strong>2006</strong> by<br />

Frans De Waal (Emory Univ. Atlanta, USA) and the<br />

announcement of the winner of the <strong>Rudolf</strong> <strong>Magnus</strong><br />

Research Award <strong>2006</strong>.<br />

<strong>UMC</strong> <strong>Utrecht</strong>, 13:30-17:15. Programme to be announced, check<br />

our website for updates, http://www.rudolfmagnus.nl<br />

Contact, m.vandenadort@med.uu.nl<br />

November 8, <strong>Rudolf</strong> <strong>Magnus</strong> Evening<br />

A unique mixture of social and scientific events is<br />

organised following the <strong>Rudolf</strong> <strong>Magnus</strong> Symposium.<br />

<strong>UMC</strong> <strong>Utrecht</strong>, 18:00-<strong>21</strong>:30, programme will include diner, details to<br />

be announced. The evening programme is only (and freely)<br />

accessible for all members of the <strong>Rudolf</strong> <strong>Magnus</strong> Institute.<br />

Registration is required, contact, m.vandenadort@med.uu.nl<br />

© <strong>2006</strong> <strong>Rudolf</strong> <strong>Magnus</strong> Institute editor Jan Dekker photography Chris Timmers print Zuidam&Uithof ISSN 1574-3071

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!